Table 1.
Characteristics and clinical features of VKH patients with SGF.
| Sex | Age | Disease duration (M) | LogMAR (R/L) | IOP | Cor | Cyc | |
|---|---|---|---|---|---|---|---|
| CVKH2 | M | 51 | 26 | −0.18/−0.18 | 13/13 | 0 | − |
| CVKH3 | M | 33 | 20 | −0.18/−0.08 | 10/9 | 3840 | + |
| CVKH4 | F | 50 | 59 | −0.18/−0.08 | 12/14 | 18350 | − |
| CVKH5 | F | 67 | 61 | 0/−0.08 | 11/15 | 5245 | − |
| CVKH6 | M | 68 | 29 | 0/0 | 13/12 | 4690 | − |
| CVKH7 | F | 81 | 49 | −0.08/0.05 | 12/12 | 10908 | − |
| CVKH9 | F | 79 | 47 | −0.08/0 | 17/16 | 0 | + |
| CVKH10 | F | 41 | 85 | −0.08/0.08 | 17/15 | 0 | − |
| CVKH11 | F | 54 | 31 | 0.22/0.1 | 11/13 | 17219 | + |
| CVKH13 | M | 64 | 83 | −0.18/−0.18 | 12/13 | 9873 | − |
| CVKH14 | F | 37 | 35 | −0.18/−0.08 | 13/13 | 6385 | − |
| CVKH15 | M | 75 | 73 | −0.18/−0.18 | 14/14 | 7752 | − |
| CVKH16 | M | 51 | 27 | −0.18/−0.18 | 12/11 | 10255 | − |
| CVKH17 | F | 53 | 78 | −0.05/−0.18 | 16/17 | 10393 | − |
| CVKH18 | F | 29 | 21 | 0.4/−0.18 | 15/16 | 3840 | − |
| CVKH19 | M | 77 | 38 | 0.1/0.15 | 11/11 | 15805 | − |
| CVKH20 | M | 64 | 39 | −0.18/−0.18 | 12/11 | 14674 | − |
IOP, intraocular pressure; Cor, corticosteroids; Cyc, cyclosporine.